Shire Pharmaceuticals

Biotech · Acquired

small molecule and biologic therapeutics for ADHD and rare diseases including ophthalmology

shire.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
11
0 granted · 11 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1670AXONEURAL THERAPEUTICS, INC.——
1671Ef Therapeutics LLC——
1672PELAGOS PHARMACEUTICALS, INC.——
1673Shire Pharmaceuticals——
1674PHOTOCHEM TECHNOLOGIES, LLC——
1675Deep Creek Pharma, LLC——
1676Cubist Pharmaceuticals——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 11
  • Methods Of Treatment Using An Amphetamine Prodrugapplication
  • Amphetamine Prodrug And Crystalline Froms Thereofapplication
  • Salts Of Amphetamine-homoarginine Conjugate Prodrugapplication
  • Methos Of Treatment Using An Amphetamine Prodrugapplication
  • Crystalline Forms Of An Amphetamine Prodrugapplication
  • Salts Of Amphetamine-homoarginine Conjugate Prodrugapplication
  • Transdermal Delivery Of Meptazinolapplication
  • Transdermal Delivery Of Meptazinolapplication
  • Quinazoline Derivatives And Their Use In The Treatment Of Thrombocythemiaapplication
  • Quinazoline Derivatives Useful For The Treatment Of Peripheral Arterial Disease And As Phosphodiesterase Inhibitorsapplication
  • Method Of Treating Hyperphosphataemia Using Lanthanum Hydroxycarbonateapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.